Over the past century, human health has been enhanced by antimicrobial development.
Following the deployment of the first antibiotics in the 1940s, bacterial resistance evolved …

Few classes of natural products rival the structural audacity of oligosaccharides. Their
complexity, however, has stood as an immense roadblock to translational research, as …

Surface-associated bacterial communities called biofilms are ubiquitous in nature. Biofilms
are detrimental in medical settings due to their high tolerance to antibiotics and may alter the …

Acinetobacter baumannii is a serious threat to human health, per the Centers for Disease
Control and Prevention's latest threat assessment. A. baumannii is a Gram-negative …

Nucleic Acid Therapeutics (NATs) are establishing a leading role for the management and
treatment of genetic diseases following FDA approval of nusinersen, patisiran, and givosiran …

Maternal environmental enteric dysfunction (EED) encompasses undernutrition with an
inflammatory gut profile, a variable degree of dysbiosis and increased translocation of …

Streptococcus agalactiae or Group B Streptococcus (GBS) is a Gram‐positive bacterial
pathobiont that is the etiological cause of severe perinatal infections. GBS can colonize the …

Preterm birth affects nearly 10% of all pregnancies in the United States, with 40% of those
due, in part, to infections. Streptococcus agalactiae (Group B Streptococcus, GBS) is one of …

Abstract Group B Streptococcus (GBS) is an encapsulated Gram‐positive bacterial pathogen
that causes severe perinatal infections. Human milk oligosaccharides (HMOs) are short …

The most common precursors to synthetic glycoproteins are reducing end glycosyl amines.
To afford these amines, a carbohydrate is reacted with an excess of an ammonia source to …